Stromal TGFβR2 signaling: a gateway to progression for pancreatic cancer
- PMID: 27308449
- PMCID: PMC4905287
- DOI: 10.4161/23723556.2014.975606
Stromal TGFβR2 signaling: a gateway to progression for pancreatic cancer
Abstract
The function of transforming growth factor β (TGFβ) in the progression of pancreatic ductal adenocarcinoma (PDA) is complex and therapeutic targeting of this pathway is challenging. We showed that antibody-mediated inhibition of stromal Tgfβr2 prevented or reversed epithelial plasticity resulting in a potent reduction of metastasis in xenograft models of PDA.
Keywords: TGF-β; epithelial to mesenchymal transition; metastasis; pancreatic cancer; tumor–stroma interactions.
Figures
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29; PMID:22237781; http://dx.doi.org/ 10.3322/caac.20138 - DOI - PubMed
-
- Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321:1801-6; PMID:18772397; http://dx.doi.org/ 10.1126/science.1164368 - DOI - PMC - PubMed
-
- Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 2010; 31:220-7; PMID:20538542; http://dx.doi.org/ 10.1016/j.it.2010.04.002 - DOI - PMC - PubMed
-
- Ostapoff KT, Cenik BK, Wang M, Ye R, Xu X, Nugent D, Hagopian MM, Topalovski M, Rivera LB, Carroll KD, et al. Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. Cancer Res 2014; 74:4996-5007; PMID:25060520; http://dx.doi.org/ 10.1158/0008-5472.CAN-13-1807 - DOI - PMC - PubMed
-
- Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39-51; PMID:20371344; http://dx.doi.org/ 10.1016/j.cell.2010.03.014 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources